Enovis Net Total Equity Issued/Repurchased 2010-2024 | ENOV
Enovis net total equity issued/repurchased from 2010 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
| Enovis Annual Net Total Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $2 |
| 2023 | $2 |
| 2022 | $6 |
| 2021 | $745 |
| 2020 | $4 |
| 2019 | $296 |
| 2018 | $-195 |
| 2017 | $7 |
| 2016 | $-19 |
| 2015 | $-21 |
| 2014 | $594 |
| 2013 | $324 |
| 2012 | $757 |
| 2011 | $4 |
| 2010 | $1 |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.041B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.307B | 54.29 |
| Hims & Hers Health (HIMS) | United States | $13.112B | 136.23 |
| Tempus AI (TEM) | United States | $10.781B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.503B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.415B | 68.98 |
| Privia Health (PRVA) | United States | $3.036B | 207.50 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.529B | 0.00 |
| Omnicell (OMCL) | United States | $1.315B | 23.21 |
| Azenta (AZTA) | United States | $1.223B | 56.83 |
| 10x Genomics (TXG) | United States | $1.125B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Talkspace (TALK) | United States | $0.500B | 149.50 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.368B | 816.67 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.147B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |